Clinical Trials Insight: 700043674
Phase of Trial: Phase I
Latest Information Update: 11 Jan 2010
At a glance
- Drugs ApoB SNALP (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions
- Sponsors Tekmira Pharmaceuticals Corporation
- 11 Jan 2010 Status changed to completed, based on information from a Temkira media release.
- 02 Jul 2009 Status changed from not yet recruiting to recruiting as reported by Tekmira Pharmaceuticals.
- 07 May 2009 Status changed from planning to not yet recruiting.